Free Newsletter
Cancer stem cells needed for metastatic growth
Researchers from Ludwig-Maximilians-University in Munich have determined that cancer stem cells govern metastasis in pancreatic cancer as well as making tumors resistant to chemotherapy. Patrick Hermann and colleagues focused specifically on pancreatic cancer, but scientists in the field say that it's a validation of other research that has identified a specific set of stem cells as playing a pivotal role in advancing a variety of cancers. Cancer stem cells are characterized by the cell surface antigen CD133. A subset of CD133 cells formed tumors and metastases when injected into mice. Compounds that attack these specific cells could play a big role in future anti-cancer therapies.
- read the article from The Scientist
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: